Correction: Phase 1A/1B dose-escalation and -expansion study to evaluate the safety, pharmacokinetics, food effects and antitumor activity of pamiparib in advanced solid tumours.

Lickliter, Jason D; Voskoboynik, Mark; Mileshkin, Linda; Gan, Hui K; Kichenadasse, Ganessan; Zhang, Kathy; Zhang, Maggie; Tang, Zhiyu; Millward, Michael

doi:10.1038/s41416-021-01671-9

Austin Health

Title

Correction: Phase 1A/1B dose-escalation and -expansion study to evaluate the safety, pharmacokinetics, food effects and antitumor activity of pamiparib in advanced solid tumours.

Publication Date

2022-02

Author(s)

Lickliter, Jason D

Voskoboynik, Mark

Mileshkin, Linda

Gan, Hui K

Kichenadasse, Ganessan

Zhang, Kathy

Zhang, Maggie

Tang, Zhiyu

Millward, Michael

Type of document

Journal Article

OrcId

0000-0001-9923-5149

0000-0002-1744-1617

0000-0001-7319-8546

DOI

10.1038/s41416-021-01671-9

Link

link

Citation

British Journal of Cancer 2021; 126(2): 310.

Jornal Title

British Journal of Cancer

Files:

Name	Size	format	Description	Link